Efficient

• Multiverse Computing has secured up to $570 million in Series C funding, bringing the company's pre-money valuation to $1.7 billion. • The firm is evolving from a provider of LLM compression technology into a comprehensive AI foundry and Operating System, bridging infrastructure and application layers. • This investment follows explosive financial growth, including a tenfold increase in annualized revenue since June 2025 and a 96-fold year-on-year surge in Q1 2026 sales.

• Multiverse Computing has announced a Series C fundraising round targeting up to $570 million (€500 million) to advance efficient AI across edge and cloud environments. • The funding round is led by a consortium including Forgepoint Capital International, BNPP Solar Impulse Venture Fund, and Bullhound Capital. • The capital will support the company's goal of powering "Frontier AI" and Large Language Models (LLMs) through its CompactifAI technology, which optimizes model efficiency.

• South Korean travel behavior is undergoing a structural shift in 2026, with travelers prioritizing "time-efficient getaways" and high entertainment density. • Japan currently dominates this trend via Tokyo and Osaka, though China is rapidly gaining market share through Shanghai and expanded connectivity. • Taipei and Hong Kong continue to serve as strong supporting destinations by offering a blend of urban experiences and nature tourism.

• Mid-sized UK institutional investors are shifting their focus from identifying opportunities in European markets to optimizing the execution of those investments. • The move is driven by a desire for better portfolio diversification, access to specialized investment strategies, and proximity to a wider range of asset classes. • This trend is expected to accelerate as financial markets undergo further digitization, specifically through the tokenization of securities.

• Anthropic announced the acquisition of Coefficient Bio, a U.S.-based AI startup specializing in biological modeling, on April 27, 2026. • The deal aims to integrate Coefficient's protein design AI tools with Anthropic's Claude models for advanced drug discovery applications. • This move positions Anthropic in the competitive AI-biotech space amid rising investments, potentially accelerating personalized medicine breakthroughs.

• Anthropic expanded its AI strategy by acquiring AI drug discovery startup Coefficient Bio for approximately $400 million and launching a political action committee to influence AI regulation. • The company is also seeing surging investor demand for its shares amid tightening AI infrastructure supply and growing market appetite. • These moves position Anthropic to shape policy, enter life sciences, and capitalize on demand for leading AI technologies in the US.

• Anthropic acquired Coefficient Bio, a startup founded eight months ago with fewer than 10 employees, for roughly $400 million in shares, despite it having no product or revenue. • The platform uses AI for pharmaceutical tasks like drug research planning and identifying new drug opportunities, positioning Anthropic's models for scientific discovery in life sciences. • This bet signals a strategic push into AI-driven biotech, potentially accelerating drug development amid growing competition in applied AI verticals.

• Anthropic acquired startup Coefficient Bio for more than $400 million to bolster its AI capabilities amid recent challenges like a source code leak. • The deal follows Anthropic's npm packaging error exposing Claude Code's source code, including memory architecture and model roadmap. • This acquisition strengthens Anthropic's position despite setbacks, potentially aiding future developments in autonomous AI features.